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Abstract
Intraoperative surgical blood loss is initially replaced by
infusion of red cell-free, cristalloidal or colloidal solu-
tions. When normovolemia is maintained the ensuing
dilutional anemia is compensated by an increase of car-
diac output and of arterial oxygen extraction. In the ideal
case, a surgical blood loss can entirely be ‘bridged’ with-
out transfusion by intraoperative normovolemic hemo-
dilution. However major blood loss results in extreme
hemodilution and the transfusion of red blood cells may
finally become necessary to increase arterial oxygen
content and to preserve tissue oxygenation. When trans-
fusion has to be started before surgical control of bleed-
ing has been achieved, parts of the red blood cells trans-
fused will get lost, thereby increasing intraoperative
transfusion needs. Beside red blood cell transfusion,
arterial oxygen content can be rapidly increased by ven-
tilating the patient with 100% oxygen (hyperoxic ventila-
tion), thus enhancing the amount of physically dissolved
oxygen in plasma (hyperoxia). In experimental and clini-
cal studies hyperoxic ventilation has emerged as a sim-
ple, safe and effective intervention to enlarge the margin
of safety for hemodynamic compensation and tissue
oxygenation in hemodiluted subjects experiencing ma-
jor bleeding. The hyperoxia-associated microcirculatory
dysregulation and impaired tissue oxygenation known
to take place in the presence of a physiologic hemoglo-
bin concentration are not encountered in hemodiluted
subjects. Hyperoxic hemodilution i.e. the combination of
intraoperative extreme hemodilution and hyperoxic ven-
tilation may therefore be considered a cost-effective,
safe and efficient supplement to reduce allogeneic trans-
fusion during surgical interventions associated with high
blood losses. The vast majority of the experimental and
clinical investigations this new concept is based on was
initiated and performed under the guidance of Prof. Kon-
rad Messmer.
Copyright © 2002 S. Karger AG, Basel
Fluid Replacement of Surgical Blood Loss
The transfusion of allogeneic blood is expensive and –
although safer than ever before – still associated with
potential complications (acute transfusion reaction due to
‘clerical error’, transfusion-related bacterial and viral in-
fection, immunosuppression). To reduce both, costs and
immanent risks, allogeneic transfusion should either be
completely avoided or at least minimized during surgical
procedures. This can be achieved by (1) intraoperative
transfusion of autologous blood collected preoperatively
(autologous blood donation, acute normovolemic hemo-
dilution) or intraoperatively (blood salvage), (2) reduction
of the amount of blood loss (skillful surgical technique,
deliberate hypotension, administration of antifibrinolytic
drugs), and (3) acceptance of low intraoperative hemoglo-
bin (Hb) concentrations.
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Fig. 1. Oxygen response of parenchymal ar-
terioles of the hamster cheek pouch in situ
(intravital microscopy). Arterioles were suf-
fused with a normal saline solution equili-
brated to different oxygen partial pressures
(x-axis). The mean arteriolar diameter (B
SEM) is depicted on the y-axis. Adapted
from Jackson and Duling [25].
Since it is known for a long time that adequate tissue
oxygenation does not depend on a ‘normal’ hemoglobin
concentration [1] an intraoperative blood loss is initially
replaced by erythrocyte-free, i.e. cristalloidal or colloidal
solutions (e.g. Ringer’s lactate, dextran, hydroxyethyl
starch, gelatine). As long as normovolemia is maintained
the resulting dilutional anemia is compensated without
risk of tissue hypoxia through an increase of cardiac out-
put (through an increase of ventricular stroke volume)
and enhanced arterial oxygen extraction [2, 3]. In the ide-
al case, a surgical blood loss can be ‘bridged’ without allo-
geneic blood transfusion by intraoperative normovolemic
hemodilution. However, once the Hb has dropped to val-
ues recommended as the lower intraoperative limit (Hb
6 g/dl in healthy subjects or Hb 8–10 g/dl in patients with
preexisting cardiovascular disease [4, 5]) or once so-called
‘transfusion-trigger’ parameters (e.g. oxygen consump-
tion, mixed-venous oxygen partial pressure, ST segment
depression in ECG) indicate the exhaustion of the com-
pensatory mechanisms for dilutional anemia , as a rule
transfusion of red blood cells is initiated to increase arteri-
al oxygen content and to preserve a margin of safety for
tissue oxygenation and organ function. When transfusion
has to be started prior to definite surgical control of bleed-
ing, the overall need for transfusion increases due to the
partial loss of the red blood cells transfused.
Effects of Hyperoxic Ventilation in Extreme
Hemodilution
Hyperoxia
As an alternative to the immediate transfusion of red
blood cells, ventilation with 100% oxygen (hyperoxic ven-
tilation) can be employed to rapidly raise arterial oxygen
content by increasing the amount of physically dissolved
oxygen in plasma (hyperoxia). Because of the linear rela-
tionship between arterial partial pressure of oxygen, paO2,
and arterial oxygen content in plasma, the quantity of
oxygen dissolved depends only upon arterial pO2 and
plasma volume. Since in hemodiluted subjects the plasma
compartment is significantly increased, plasma becomes
an important source of oxygen [6].
Hyperoxic Vasoconstriction
Molecular oxygen causes vasoconstriction. This effect
of hyperoxia on large vessels as well as on microvessels
(arterioles, venules) has been extensively demonstrated in
vitro (isolated vessel segments [7]) and in vivo (intravital
microscopy [8], laser doppler flowmetry [9] etc.; see
fig. 1). It seems to be locally mediated [10] by products of
the arachidonic acid metabolic pathway (e.g. 20-hydroxy-
eicosa-tetraenoic acid, briefly 20-HETE [11]) and can be
completely blocked by indomethacin [12] and cyto-
chrome P-450 inhibitors [11]. Hyperoxia has been shown
to increase systemic vascular resistance and to decrease
cardiac output and oxygen consumption in subjects with
normal hemoglobin concentration [13]. The simulta-
neously observed deterioration of tissue oxygenation has
been interpreted as to reflect impaired local oxygen deliv-
ery due to hyperoxic vasoconstriction and abnormal spa-
tial and temporal distribution of microvascular blood
flow [14]. As a consequence hyperoxia at normal hemo-
globin concentrations is considered harmful concerning
tissue integrity and function.
In our own experiments carried out in hemodiluted
dogs (Hb 7 g/dl) [6] hyperoxia completely reversed the
hemodilution-induced increase of cardiac index and par-
tially reversed the decrease of systemic vascular resistance
(fig. 2). Nevertheless, the normal Gaussian distribution of
single tissue pO2 values measured by means of an oxygen-
sensitive multiwire surface electrode was preserved dur-
ing hyperoxia (fig. 3). A higher number of hypoxic tissue
pO2 values (0–15 mm Hg) was not detected and the shift-
ing of the histograms to the right (increase of tpO2
median) may even indicate improved tissue oxygenation.
Moreover non-linear analysis of blood flow distribution
did not reveal any increase in heterogeneity of microcir-
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Fig. 2. Changes in arterial oxygen content (CaO2), cardiac index (CI) and systemic vascular resistance index (SVRI)
upon normovolemic hemodilution on room-air ventilation (21% oxygen) to a hemoglobin concentration of 7 g/dl
(filled bars) and after subsequent onset of hyperoxic ventilation (100% oxygen; hatched bar). Adapted from Habler et
al. [6]. * p ! 0.05; ‘Hb 12.7 g/dl, room-air’ vs. ‘Hb 7 g/dl, room-air’; # p ! 0.05; ‘Hb 7 g/dl, room-air’ vs. ‘Hb 7 g/dl,
hyperoxic ventilation’; § p ! 0.05; ‘Hb 12.7 g/dl, room-air’ vs. ‘Hb 7 g/dl, hyperoxic ventilation’.
Fig. 3. Frequency distribution of tissue pO2 values measured on the surface of the liver and a skeletal muscle by use of
an oxygen sensitive surface electrode (MDO electrode) in anesthetized dogs hemodiluted to Hb 7 g/dl under room-air
ventilation (21% oxygen) and after onset of hyperoxic ventilation (100% oxygen). Adapted from Habler et al. [6]. * p !
0.05; ‘Hb 7 g/dl, FiO2 0.21’ vs. ‘Hb 7 g/dl, FiO2 1.0’.
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Fig. 4. Schematic depiction of changes in arteriolar diame-
ter when hyperoxic ventilation is performed (1) in subjects
with physiologic hemoglobin concentration (left side) and
(2) in hemodiluted subjects (right side). Hemodilution-
induced vasodilation compensates hyperoxic vasoconstric-
tion [26].
Fig. 5. Frequency distribution of tissue pO2 values measured on the surface of the liver and a skeletal muscle by use of
an oxygen-sensitive surface electrode (MDO electrode) in anesthetized dogs hemodiluted under room-air ventilation
(21% oxygen) and physiologic hemoglobin concentration (Hb 13 g/dl) and after extreme hemodilution (Hb 3 g/dl)
under hyperoxic ventilation (100% oxygen). Adapted from Habler et al. [6, 19].
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Fig. 6. Frequency distribution of tissue pO2 values measured on the
surface of a skeletal muscle by use of an oxygen-sensitive surface elec-
trode (MDO electrode) in anesthetized pigs hemodiluted under
room-air ventilation (21% oxygen) until occurrence of tissue hypoxia
(Hb 2.6 g/dl) and after onset of hyperoxic ventilation (100% oxygen).
Kemming et al., unpublished data. # p ! 0.05; ‘Hb 10 g/dl, FiO2 0.21’
vs. ‘Hb 2.6 g/dl, FiO2 0.21’; * p ! 0.05; ‘Hb 2.6 g/dl, FiO2 0.21’ vs.
‘Hb 2.6 g/dl, FiO2 1.0’.
Fig. 7. Survival after acute normovolemic hemodilution (ANH)
under room-air ventilation (21% oxygen) to the critical hemoglobin
concentration (Hbcrit) i.e. until occurrence of manifest tissue hypoxia.
For the following 6 h animals were either further ventilated with
room air (n = 7, dotted line) or with 100% oxygen (hyperoxic ventila-
tion; n = 7, solid line). Meier et al., unpublished data.
culatory blood flow during hyperoxia in hemodiluted ani-
mals [15, 16]. These findings demonstrate the pivotal role
of the actual Hb concentration on the microcirculatory
effects of hyperoxia. The increase of organ blood flow
induced by hemodilution (i.e. normovolemic anemia) in-
creases shear stress at the vessel wall which in turn induces
the release of endothelium-derived relaxing factor (i.e. nit-
ric oxide, NO) and hence vasodilation [17, 18]. It can there-
fore be speculated that in dilutional anemia the microcircu-
latory dysregulation due to hyperoxia is counteracted by
NO release (see schematic drawing, fig. 4).
Hyperoxia as an Alternative to Red Blood Cell
Transfusion in Surgical Blood Loss
Experimental Data
Under the ‘protection’ of hyperoxia, intraoperative
hemodilution may be extended to Hb concentrations low-
er than those usually accepted as trigger for red blood cell
transfusion as demonstrated in experimental and clinical
studies [19, 20]. In dogs initially hemodiluted on room-air
ventilation to Hb 7 g/dl, subsequent hyperoxic ventilation
allowed for further hemodilution to the extreme value of
Hb 3 g/dl without encountering significant changes in tis-
sue oxygenation (fig. 5) [19] and cardiac performance
[21]. Moreover, in pigs ventilated with room-air and
diluted until the occurrence of manifest tissue hypoxia
(Hb 2.6 g/dl), subsequent ventilation with 100% oxygen
was not only able to effectively reverse tissue hypoxia
(fig. 6), but allowed to extend the dilution to Hb 1.2 g/dl
i.e. almost complete blood exchange before the signs of
tissue hypoxia reoccurred [Kemming et al., unpublished
data]. Finally, in the presence of hemodilution-induced
tissue hypoxia, an effective tissue utilization of physically
dissolved plasma oxygen has been proven evidenced by a
significantly higher survival rate of pigs ventilated with
100% oxygen as compared to pigs remaining under room
air ventilation (fig. 7; Meier et al., unpublished data).
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Fig. 8. Hyperoxic hemodilution, i.e. the combination of hyperoxic
ventilation and extreme intraoperative hemodilution as an alterna-
tive to red blood cell transfusion in patients undergoing elective sur-
gical interventions and experiencing major intraoperative bleeding.
Schematic flow diagram. The left branch of the decision tree repre-
sents the usual transfusion practice, the right branch depicts the new
concept of bridging a surgical blood loss by extreme hemodilution
under the protection of hyperoxic ventilation introduced into the lit-
erature by our group as ‘hyperoxic hemodilution’ [24].
Clinical Data
In patients experiencing major intraoperative bleeding
during orthopedic surgery, the indication for red cell
transfusion (based on the appearence of physiologic trig-
ger parameters) could be reversed in two thirds of the
patients by the simple switch from ventilation with 40%
oxygen to hyperoxic ventilation with 100% oxygen. This
manoeuvre enabled the continuation of intraoperative
hemodilution and the definite need for red blood cell
transfusion could be postponed for 27–60 min (median
30 min) [20]. This gain in time may at least help the sur-
geon to definitely control bleeding, or to complete the sur-
gical intervention before red blood cell transfusion be-
comes necessary. The augmentation of blood oxygen
transport capacity indispensible to reduce inspiratory ox-
ygen fraction to values allowing extubation of the patient
may then be achieved by exclusive transfusion of allo-
geneic red blood cells collected in the perioperative peri-
od. Moreover advantageous side-effects accompanying
perioperative hyperoxia seem to be the reduction of post-
operative nausea and vomiting [22] as well as a reduced
incidence of perioperative wound infections [23].
Conclusion
Hyperoxic hemodilution, i.e. the combination of nor-
movolemic hemodilution and hyperoxic ventilation [24],
represents a safe and effective method to ‘bridge’ a surgi-
cal blood loss exclusively through infusion of erythrocyte-
free solutions. This policy may allow to delay the onset of
red blood cell transfusion until definite control of surgical
bleeding has been achieved (fig. 8). Hyperoxia-related mi-
crocirculatory dysregulation and impaired tissue oxygen-
ation both characteristic features at physiologic Hb con-
centrations are completely absent in hemodiluted sub-
jects. Hyperoxic hemodilution may therefore be consid-
ered as an effective supplemental method to reduce peri-
operative allogeneic transfusion.
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